Home ›
Trademark Categories ›
Pharmaceuticals ›
2014 ›
AT ›
ATTERX BIOTHERAPEUTICS
Trademark search for:
ATTERX BIOTHERAPEUTICS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-07-16 — Application filed
2018-07-19 — Application filed
2018-07-19 — Application filed
2018-11-02 — Assigned to examiner
2018-11-14 — Final disposition recorded
2018-11-14 — Final disposition recorded
2018-11-14 — Final disposition recorded
2019-05-14 — Office action issued
2019-05-21 — Assigned to lie
2019-05-22 — Correspondence received in law office
2019-05-22 — Teas/email correspondence entered
2019-05-22 — Approved for pub - principal register
2019-06-05 — Notification of notice of publication e-mailed
2019-06-25 — Published for opposition
2019-06-25 — Official gazette publication confirmation e-mailed
2019-08-20 — Noa e-mailed - sou required from applicant
2020-02-14 — Sou teas extension received
2020-02-14 — Sou extension 1 filed
2020-02-14 — Sou extension 1 granted
2020-02-18 — Notice of approval of extension request e-mailed
2020-08-19 — Sou teas extension received
2020-08-19 — Sou extension 2 filed
2020-08-19 — Sou extension 2 granted
2020-08-21 — Notice of approval of extension request e-mailed
2021-02-17 — Sou teas extension received
2021-02-17 — Sou extension 3 filed
2021-02-17 — Sou extension 3 granted
2021-02-19 — Notice of approval of extension request e-mailed
2021-08-13 — Sou teas extension received
2021-08-13 — Sou extension 4 filed
2021-08-13 — Sou extension 4 granted
2021-08-17 — Notice of approval of extension request e-mailed
2022-01-28 — Teas revoke/app/change addr of atty/dom rep received
2022-01-28 — Attorney/dom.rep.revoked and/or appointed
2022-01-28 — Teas withdrawal of attorney received-firm retains
2022-01-28 — Teas change of correspondence received
2022-01-31 — Sou teas extension received
2022-01-31 — Sou extension 5 filed
2022-02-04 — Case assigned to intent to use paralegal
2022-02-04 — Sou extension 5 granted
2022-02-05 — Notice of approval of extension request e-mailed
2022-09-26 — Application abandoned
2022-09-26 — Application abandoned
2022-09-26 — Final status recorded
Owner Information
Atterx BioTherapeutics, Inc.
Atterx BioTherapeutics, Inc.
Correspondent
Thomas Lyneis GODFREY & KAHN, S.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
